Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer
2013-002742-37Phase 2Completed
- Sponsor
- AIO-Studien
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tegafur in Esophagogastric Cancer (2 arms), sponsored by AIO-Studien. Primary endpoint: Overall survival. Started May 2014; status: completed.
02
Drugs
tegafur
03
Conditions
Esophagogastric Cancer
Beyond the preview
Go deeper on 2013-002742-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002742-37.